{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:47:26Z","timestamp":1759063646700},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"vor","delay-in-days":2788,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian Journal of Medical Microbiology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.4103\/0255-0857.118882","type":"journal-article","created":{"date-parts":[[2013,9,25]],"date-time":"2013-09-25T14:47:22Z","timestamp":1380120442000},"page":"360-365","source":"Crossref","is-referenced-by-count":7,"title":["Mutation analysis of hepatitis B virus reverse transcriptase region among untreated chronically infected patients in Ahvaz city (South-West of Iran)"],"prefix":"10.1016","volume":"31","author":[{"given":"M","family":"Hamidi-Fard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Makvandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Samarbaf-Zadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Hajiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Shayesteh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Masjedizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4103\/0255-0857.118882_bib1","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.23190","article-title":"Chronic hepatitis B: Update 2009","volume":"50","author":"Lok","year":"2009","journal-title":"Hepatology"},{"key":"10.4103\/0255-0857.118882_bib2","first-page":"5","article-title":"Diagnosis and treatment of chronic hepatitis B: 2009 update","volume":"55","author":"Morgan","year":"2009","journal-title":"Minerva Gastroenterol Dietol"},{"key":"10.4103\/0255-0857.118882_bib3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2893.2009.01078.x","article-title":"Chronic hepatitis B: Early viral suppression and long-term outcomes of therapy with oral nucleos (t) ides","volume":"16","author":"Nguyen","year":"2009","journal-title":"J Viral Hepat"},{"key":"10.4103\/0255-0857.118882_bib4","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1872-034X.2011.00873.x","article-title":"Hepatitis B virus drug resistance to current nucleos (t) ide analogs: Mechanisms and mutation sites","volume":"41","author":"Deng","year":"2011","journal-title":"Hepatol Res"},{"key":"10.4103\/0255-0857.118882_bib5","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1128\/AAC.00239-06","article-title":"Emergence of a novel lamivudine-resistant hepatitis B virus variant with a substitution outside the YMDD motif","volume":"50","author":"Yatsuji","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4103\/0255-0857.118882_bib6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1386-6532(02)00049-5","article-title":"The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus","volume":"25","author":"Torresi","year":"2002","journal-title":"J Clin Virol"},{"key":"10.4103\/0255-0857.118882_bib7","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.antiviral.2011.08.013","article-title":"Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, na\u00efve to antiviral drugs","volume":"92","author":"Salpini","year":"2011","journal-title":"Antiviral Res"},{"key":"10.4103\/0255-0857.118882_bib8","doi-asserted-by":"crossref","first-page":"e32789","DOI":"10.1371\/journal.pone.0032789","article-title":"The naturally occurring YMDD mutation among patients chronically infected HBV and untreated with lamivudine: A systematic review and meta-analysis","volume":"7","author":"Tan","year":"2012","journal-title":"PLoS One"},{"key":"10.4103\/0255-0857.118882_bib9","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/nar\/gkh419","article-title":"A web-based genotyping resource for viral sequences","volume":"32","author":"Rozanov","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"10.4103\/0255-0857.118882_bib10","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.antiviral.2010.09.012","article-title":"Hepatitis B virus reverse transcriptase sequence database for sequence analysis and mutation discovery","volume":"88","author":"Rhee","year":"2010","journal-title":"Antiviral Res"},{"key":"10.4103\/0255-0857.118882_bib11","first-page":"835","article-title":"Frequency and mutation patterns of resistance in patients with chronic hepatitis B infection treated with Nucleos (t) ide analogs in add-on and switch strategies","volume":"11","author":"Sayan","year":"2011","journal-title":"Hepat Mon"},{"key":"10.4103\/0255-0857.118882_bib12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijid.2007.05.001","article-title":"Hepatitis B virus (HBV) genotype and YMDD motif mutation profile among patients infected with HBV and untreated with lamivudine","volume":"12","author":"Amini-Bavil-Olyaee","year":"2008","journal-title":"Int J Infect Dis"},{"key":"10.4103\/0255-0857.118882_bib13","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3851\/IMP1465","article-title":"Pretreatment with pegylated interferon prevents emergence of lamivudine mutants in lamivudine naive patients: A pilot study","volume":"14","author":"Villa","year":"2009","journal-title":"Antivir Ther"},{"key":"10.4103\/0255-0857.118882_bib14","first-page":"652","article-title":"Clinical analysis of natural mutation of YMDD in HBV infection patients","volume":"9","author":"Wang","year":"2009","journal-title":"China Trop Med"},{"key":"10.4103\/0255-0857.118882_bib15","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/jmv.23200","article-title":"Characterization of hepatitis B virus genome variability in Iranian patients with chronic infection, a nationwide study","volume":"84","author":"Mohebbi","year":"2012","journal-title":"J Med Virol"},{"key":"10.4103\/0255-0857.118882_bib16","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jhep.2005.05.037","article-title":"Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensation","volume":"43","author":"Fung","year":"2005","journal-title":"J Hepatol"},{"key":"10.4103\/0255-0857.118882_bib17","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1056\/NEJMoa042957","article-title":"Longterm therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B","volume":"352","author":"Hadziyannis","year":"2005","journal-title":"N Engl J Med"},{"key":"10.4103\/0255-0857.118882_bib18","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1177\/135965350901400416","article-title":"Adefovir dipivoxil resistance patterns in patients with lamivudine-resistant chronic hepatitis B","volume":"14","author":"Santantonio","year":"2009","journal-title":"Antivir Ther"},{"key":"10.4103\/0255-0857.118882_bib19","first-page":"5211","article-title":"Preliminary report of hepatitis B virus genotype prevalence in Iran","volume":"12","author":"Alavian","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.4103\/0255-0857.118882_bib20","first-page":"42","article-title":"Molecular diagnosis of entecavir resistance","volume":"10","author":"Sayan","year":"2010","journal-title":"Hepat Mon"},{"key":"10.4103\/0255-0857.118882_bib21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s12072-008-9048-3","article-title":"Primary resistance, multidrug resistance, and cross-resistance pathways in HBV as a consequence of treatment failure","volume":"2","author":"Locarnini","year":"2008","journal-title":"Hepatol Int"}],"container-title":["Indian Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085721006101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085721006101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T20:50:58Z","timestamp":1688503858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0255085721006101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0255085721006101"],"URL":"https:\/\/doi.org\/10.4103\/0255-0857.118882","relation":{},"ISSN":["0255-0857"],"issn-type":[{"value":"0255-0857","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}